Evolution of Cancer Therapies: Access of Developing Countries to Modern Oncology
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Therapy".
Deadline for manuscript submissions: 28 February 2026 | Viewed by 25
Special Issue Editor
Special Issue Information
Dear Colleagues,
Conventional treatments for cancer include chemotherapy, radiation therapy, hormonal therapy, and surgery. More personalized Research advances have improved cancer treatment to make it more effective and more personalized. In fact, during the last two decades, the landscape of tumor treatment has undergone a comprehensive and remarkable transformation. The cutting-edge treatment modalities (small molecule targeted drugs, personalized vaccines, cell therapy, gene editing, and the microbiome) allowed personalized and precise tumor targeting. Currently, new approaches targeting, in particular, the immune system are bringing us closer to a future where cancer becomes a curable disease. Nevertheless, the oncological gap worldwide stands as a painful reality. Already, over half of new cancers arise in people in the developing world, and much remains to be done to raise awareness and concern about cancer in the developing world. It is therefore crucial to assist clinicians and researchers from the emerging countries in gaining a deeper understanding of these diverse treatment options, enabling them to carry out effective patient treatment.
Despite progress in the development of new cancer drugs, concerns about equity of access remain. While the gap is to be minded, there is a call for the scientific and clinical communities to share their experiences, best practices, and lessons learned to mitigate inequalities.
Prof. Dr. Salem Chouaib
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- conventional cancer therapies
- modern oncology
- recission medicine
- cancer immunotherapy
- artificial intelligence
- targeted agents
- equity and globally equal access
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
